Fundraising FoxAttgeno
Stockholm, SE · 2 known investors
Find your way into Attgeno
Sign up to see every warm intro you have to Attgeno
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Attgeno team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients. The company works in the biotech and drug development field across specific disease areas.
Founders & leadership
LE
Lars E. GustafssonCo-founder (deceased)
Board
MP
Investors · 2
Frequently asked questions
- What does Attgeno do?
- Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients. The company works in the biotech and drug development field across specific disease areas.
- Who founded Attgeno?
- Attgeno was founded by Lars E. Gustafsson.
- Who are Attgeno's investors?
- Attgeno's investors include EIR Ventures, Hadean Ventures.
- Where is Attgeno headquartered?
- Attgeno is headquartered in Stockholm, SE.